CanSinotech submitted CTA of “Diphtheria and Tetanus Toxoids and Component Pertussis Vaccine Adsorbed” to CFDA

2014.11.25

Nov 24, 2014

CanSinotech submitted Clinical Trial Application (CTA) of “Diphtheria and Tetanus Toxoids and Component Pertussis Vaccine Adsorbed” to China Food and Drug Administration.

CanSinotech owns effective patents of this vaccine candidate in China.

China’s First Ebola Vaccine Approved For Clinical Trials

CanSino awarded “Key Overseas Chinese Entrepreneurial Team